Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 28.35-21.6327.368.439.27

What is the latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS is 28.35 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202528.35
Mar2024-21.63
Mar202327.36
Mar20228.43
Mar20219.27

How is Price to Cash Earnings (PCE) of GLENMARK PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 28.35
Positive
Mar2024 -21.63
Negative
Mar2023 27.36
224.56
Mar2022 8.43
-9.06
Mar2021 9.27 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,395.4 Cr -2.4% 7% 54.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,693.0 Cr -1.7% 4% 11.8% Stock Analytics
DIVIS LABORATORIES ₹161,270.0 Cr -4.7% -1.8% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,281.0 Cr -3.7% 4.5% 42.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,422.0 Cr -3% 0% 15.4% Stock Analytics
CIPLA ₹104,915.0 Cr -2.6% -2.3% -10.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.4%

7%

54.8%

SENSEX

-2.7%

-10.4%

1.6%


You may also like the below Video Courses